Specific cross-reaction of anti-dsDNA antibody with platelet integrin GPIIIa49-66

Autoimmunity

Volumn 43, Issue 8, 2010, Pages 682-689

  Zhang, Wei ^a   Dang, Suying ^a   Wang, Jianhui ^a   Nardi, Michael A ^a   Zan, Hong ^b   Casali, Paolo ^b   Li, Zongdong ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

anti dsDNA autoantibody; Autoantibody; platelet associated antibody (PAIgG); systemic lupus erythematosus (SLE)

Indexed keywords

DOUBLE STRANDED DNA ANTIBODY; INTEGRIN;

ANIMAL EXPERIMENT; ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; CROSS REACTION; DNA BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MOLECULAR MODEL; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; BLOOD PLATELETS; COMPLEMENTARITY DETERMINING REGIONS; CROSS REACTIONS; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; HUMANS; IMMUNOBLOTTING; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED BALB C; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PLATELET COUNT; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RANDOM ALLOCATION;

EID: 78149455162     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2010.506207     Document Type: Article

References (44)

1. Atassi MZ, Casali P. Molecular mechanisms ofautoimmunity. Autoimmunity 2008;41:123-132.
2. Zan H, Zhang J, Ardeshna S, Xu Z, Park SR, Casali P. Lupus-prone MRL/faslpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: Concurrent upregu-lation of somatic hypermutation and class switch DNA recombination. Autoimmunity 2009;42:89-103.
3. Crispin JC, Liossis SN, Kis-Toth K, Lieberman LA, Kyttaris VC, Juang YT, Tsokos GC. Pathogenesis of human systemic lupus erythematosus: Recent advances. Trends Mol Med 2010;16:47-57.
4. Perl A. Pathogenic mechanisms in systemic lupus erythema-tosus. Autoimmunity 2010;43:1-6.
5. Hiraiwa A, Nugent DJ, Milner ECB. Sequence analysis of monoclonal antibodies derived from a patient with idiopathic thrombocytopenic purpura. Autoimmunity 1990;8:107-113.
6. Boumpas DT, Austin HA, III, Fessler BJ, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: Emerging concepts. Part 1: Renal, neuropsychiatric, cardio-vascular, pulmonary, and hematologic disease. Ann Intern Med 1995;122:940-950.
7. Ziakas PD, Routsias JG, Giannouli S, Tasidou A, Tzioufas AG, Voulgarelis M. Suspects in the tale of lupus-associated thrombocytopenia. Clin Exp Immunol 2006;145:71-80.
8. Ziakas PD, Poulou LS, Giannouli S, Tzioufas AG, Voulgarelis M. Thrombocytopenia in lupus: Baseline C3 as an indepen-dent risk factor for relapse. Ann Rheum Dis 2007;66: 130-131.
9. Macchi L, Rispal P, Clofent-Sanchez G, Pellegrin JL, Nurden P, Leng B, Nurden AT Anti-platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome: Their relationship with the observed thrombocytopenia. Br J Haematol 1997;98: 336-341.
10. Kuwana M, Okazaki Y, Kajihara M, Kaburaki J, Miyazaki H, Kawakami Y, Ikeda Y. Autoantibody to c-Mpl (thrombopoie-tin receptor) in systemic lupus erythematosus: Relationship to thrombocytopenia with megakaryocytic hypoplasia. Arthritis Rheum 2002;46:2148-2159.
11. McMillan R, Wang L, Tomer A, Nichol J, Pistillo J. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 2004;103:1364-1369.
12. Gernsheimer T Chronic idiopathic thrombocytopenic pur-pura: Mechanisms of pathogenesis. Oncologist 2009;14: 12-21.
13. Galli M, Daldossi M, Barbui T Anti-glycoprotein Ib/IX and IIb/IIIa antibodies in patients with antiphospholipid anti-bodies. Thromb Haemost 1994;71:571-575.
14. Tokita S, Arai M, Yamamoto N, Katagiri Y, Tanoue K, Igarashi K, Umeda M, Inoue K. Specific cross-reaction of IgG anti-phospholipid antibody with platelet glycoprotein IIIa. Thromb Haemost 1996;75:168-174.
15. Mageed RA, Zack DJ. Cross-reactivity and pathogenicity of anti-DNA autoantibodies in systemic lupus erythematosus. Lupus 2002;11:783-786.
16. Dighiero G, Guilbert B, Fermand JP, Lymberi P, Danon F, Avrameas S. Thirty-six human monoclonal immunoglobulins with antibody activity against cytoskeleton proteins, thyroglo-bulin, and native DNA: Immunologic studies and clinical correlations. Blood 1983;62:264-270.
17. Andre-Schwartz J, Datta SK, Shoenfeld Y, Isenberg DA, Stollar BD, Schwartz RS. Binding ofcytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies. Clin Immunol Immunopathol 1984;31:261-271.
18. Jacob L, Lety MA, Louvard D, Bach JF. Binding of a monoclonal anti-DNA autoantibody to identical protein(s) present at the surface of several human cell types involved in lupus pathogenesis. J Clin Invest 1985;75:315-317.
19. Pisetsky DS, Hoch SO, Klatt CL, O'Donnell MA, Keene JD. Specificity and idiotypic analysis of a monoclonal anti-Sm antibody with anti-DNA activity. J Immunol 1985;135: 4080-4085.
20. Jacob L, Lety MA, Bach JF, Louvard D. Human systemic lupus erythematosus sera contain antibodies against cell-surface protein(s) that share(s) epitope(s) with DNA. Proc Natl Acad Sci USA 1986;83:6970-6974.
21. Ternynck T, Avrameas S. Murine natural monoclonal autoantibodies: A study of their polyspecificities and their affinities. Immunol Rev 1986;94:99-112.
22. Raz E, Brezis M, Rosenmann E, Eilat D. Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J Immunol 1989;142: 3076-3082.
23. Berneman A, Ternynck T, Avrameas S. Natural mouse IgG reacts with self antigens including molecules involved in the immune response. Eur J Immunol 1992;22:625-633.
24. Banks TA, Babakhani F, Poulos BT, Duffy JJ, Kibler R. Characterization ofcross-reactive anti-DNA autoantibodies in murine lupus. Autoimmunity 1993;22:229-248.
25. Reichlin M, Martin A, Taylor-Albert E, Tsuzaka K, Zhang W, Reichlin MW, Koren E, Ebling FM, Tsao B, Hahn BH. Lupus autoantibodies to native DNA cross-react with the A and D SnRNP polypeptides. J Clin Invest 1994;93:443-449.
26. Du H, Chen M, Zhang Y, Zhao MH, Wang HY. Cross-reaction of anti-DNA autoantibodies with membrane proteins of human glomerular mesangial cells in sera from patients with lupus nephritis. Clin Exp Immunol 2006;145:21-27. (Pubitemid 43893928)
27. Elkon K, Casali P. Nature and functions of autoantibodies. Nat Rev Rheumatol 2008;4:491-498.
28. Putterman C, Diamond B. Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin depo-sition. J Exp Med 1998;188:29-38.
29. Rice JS, Kowal C, Volpe BT, DeGiorgio LA, Diamond B. Molecular mimicry: Anti-DNA antibodies bind microbial and nonnucleic acid self-antigens. Curr Top Microbiol Immunol 2005;296:137-151.
30. Karpatkin S, Nardi MA, Hymes KB. Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocyto-penic patients. Proc Natl Acad Sci USA 1995;92:2263-2267.
31. Nardi MA, Liu LX, Karpatkin S. GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocyto-penia. Proc Natl Acad Sci USA 1997;94:7589-7594.
32. Nardi M, Tomlinson S, Greco MA, Karpatkin S. Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia. Cell 2001;106:551-561. (Pubitemid 32879317)
33. Nardi M, Feinmark SJ, Hu L, Li Z, Karpatkin S. Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway. J Clin Invest 2004;113:973-980.
34. Li Z, Nardi MA, Karpatkin S. Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocyto-penia. Blood 2005;106:572-576.
35. Li Z, Nardi MA, Wu J, Pan R, Zhang W, Karpatkin S. Platelet fragmentation requires a specific structural conformation of human monoclonal antibody against beta3 integrin. J Biol Chem 2008;283:3224-3230.
36. Kasaian MT, Ikematsu H, Balow JE, Casali P. Structure of the VH and VL segments of monoreactive and polyreactive IgA autoantibodies to DNA in patients with systemic lupus erythematosus. J Immunol 1994;152:3137-3151.
37. Kasaian MT, Casali P. B-1 cellular origin and VH segment structure of IgG, IgA, and IgM anti-DNA autoantibodies in patients with systemic lupus erythematosus. Ann N Y Acad Sci 1995;764:410-423.
38. Li Z, Schettino EW, Padlan EA, Ikematsu H, Casali P. Structure-function analysis of a lupus anti-DNA autoanti-body: Central role of the heavy chain complementarity-determining region 3 Arg in binding of double-and single-stranded DNA. Eur J Immunol 2000;30:2015-2026.
39. Levin RE, Weinstein A, Peterson M, Testa MA, Rothfield NF. A comparison of the sensitivity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1984;27: 530-538.
40. Sun Y, Fong KY, Chung MC, Yao ZJ. Peptide mimicking antigenic and immunogenic epitope of double-stranded DNA in systemic lupus erythematosus. Int Immunol 2001;13: 223-232.
41. Ehrenstein MR, Swana M, Keeling D, Asherson R, Hughes GR, Isenberg DA. Anti-DNA antibodies in the primary antiphospholipid syndrome (PAPS). Br J Rheumatol 1993;32:362-365. (Pubitemid 23181986)
42. Barbas SM, Ditzel HJ, Salonen EM, Yang WP, Silverman GJ, Burton DR. Human autoantibody recognition of DNA. Proc Natl Acad Sci USA 1995;92:2529-2533.
43. Jang YJ, Stollar BD. Anti-DNA antibodies: Aspects of structure and pathogenicity. Cell Mol Life Sci 2003;60: 309-320.
44. Samuel H, Nardi M, Karpatkin M, Hart D, Belmont M, Karpatkin S. Differentiation ofautoimmune thrombocytope-nia from thrombocytopenia associated with immune complex disease: Systemic lupus erythematosus, hepatitis-cirrhosis, and HIV-1 infection by platelet and serum immunological measurements. Br J Haematol 1999;105:1086-1091.